AstraZeneca PLC (ZEGA) — Cash Flow-to-Debt Ratio
AstraZeneca PLC (ZEGA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of €5.13 Billion could theoretically repay 0% of its total liabilities (€68.48 Billion) in one year. Explore AstraZeneca PLC (ZEGA) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AstraZeneca PLC Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for AstraZeneca PLC across 11 annual periods. Also explore total assets of AstraZeneca PLC for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for AstraZeneca PLC (2014–2024)
Year-by-year debt coverage analysis for AstraZeneca PLC. For market capitalisation and broader financial context, see AstraZeneca PLC market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €11.86 Billion | €63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | €10.36 Billion | €61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | €9.81 Billion | €59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | €5.96 Billion | €66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | €4.80 Billion | €51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | €2.97 Billion | €46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | €2.62 Billion | €46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | €3.58 Billion | €46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | €4.14 Billion | €45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | €3.32 Billion | €41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | €7.06 Billion | €38.95 Billion | — |